New Variant: Emergency Use Vax Approval Granted 2 Weeks Ago!
It seems like only yesterday we were reporting on the new COVID variant coming out of Africa, but within hours there were already vaccines for the new variant.
Reuters reported yesterday:
Novavax Inc (NVAX.O) said on Friday it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks.
The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system. The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.
Novavax’s vaccine received its first emergency use approval earlier this month in Indonesia followed by the Philippines. Other vaccine developers, including Germany’s BioNTech SE and Johnson & Johnson, have said they are testing the effectiveness of their shots against the new variant, which is named Omicron by the World Health Organization
As we reported last night, other companies are ready to test their vaccine within the next two weeks as well.
The Conservative Treehouse writes:
Wow, 72 hours ago no one even heard the name Omicron variant. Now, in less than three days, a variant has been identified, global travel has been halted, states of emergency have been declared, and now we see a pharmaceutical company announcing the variant-specific vaccine trial that will begin in the U.S. in a few weeks.
This government relationship with Big Pharma is certainly generating some fast action, eh?
Yes, the miracles(?!) of modern medicine.
See more here: thegatewaypundit.com
Header image: Anadolu Agency
Editor’s note: PSI’s position is that our scientists believe COVID19 is merely influenza rebranded because the CDC, FDA and several national governments still do not show a gold standard isolate of the novel coronavirus and thus it is not proven to exist in empirical science.
Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
JaKo
| #
Very strange:
When a “deadlier than the original virus” original vaxes had to do as “boosters” as no updated shots were available, but now, when much milder strain “Oh-micron” appears, surprise, surprise! New vax is born! Rejoice!
Also, it would be interesting to get real data on covidism from Germany — i.e. rates of vaxxed vs un-vaxxed “infections” — perhaps a good translation of that California nurse’s statement about protecting the unprotected shall be made available to the Germans (remember Monty P’s deadly joke?)…
Cheers, JaKo
Reply
Charles Higley
| #
This vaccine still only elicits antibodies against one viral protein. What about the other 26 viral proteins.
By definition, this vaccine will foster antibody dependent enhancement as it fosters non-neutralizing antibodies.
Reply